A meta-analysis by Burger et al.8 found that 24.9% of patients had at least one Ta or T1 tumour detected only by BLC and 26.7% of patients had at least one CIS lesion detected only by BLC (P < 0.001). Here, CXCL13 is linked to in situ carcinoma.